Germline and somatic variation influence nuclear-mitochondrial crosstalk in tumourigenesis
Authors:
- Maëlle DaunesseMDMaëlle Daunesse
- Vasavi SundaramVSVasavi Sundaram
- Elissavet KentepozidouEKElissavet Kentepozidou
- John ConnellyJCJohn Connelly
- Craig J. AndersonCACraig J. Anderson
- Liver Cancer Evolution ConsortiumLCLiver Cancer Evolution Consortium
- Núria López-BigasNLNúria López-Bigas
- Colin A. SempleCSColin A. Semple
- Duncan T. OdomDODuncan T. Odom
- Martin S. TaylorMTMartin S. Taylor
- Maša RollerMRMaša Roller
- Sarah J. AitkenSASarah J. Aitken
Preprint
Abstract
Hepatocellular carcinoma is the most prevalent primary liver cancer and arises from hepatocytes, which are very metabolically active and contain abundant mitochondria. Despite extensive characterisation of nuclear driver genes and pathways, the role of crosstalk between the mitochondrial and nuclear genomes in mitochondrial mutagenesis remains poorly understood. To address this, we leveraged a chemical carcinogenesis model of liver cancer in four mouse strains. We analysed hundreds of tumours with paired whole-genome sequencing and total RNA sequencing to comprehensively characterise mitochondrial mutations and expression. Following de novo assembly of strain-specific mitochondrial genomes, we devised an accurate and efficient heteroplasmy detection approach and analysed mitochondrial DNA (mtDNA) content and transcription. Across strains, there was high concordance of the number of heteroplasmies, mutation signatures, and variant allele frequencies. In contrast, the heteroplasmy rate and genic locations differed between strains, suggesting strain-specificity in DNA repair mechanisms in early tumour development. Independent of age or environmental factors, tumours had lower mtDNA content than adjacent normal liver, suggesting mitochondrial loss during tumourigenesis. Additionally, within individual strains, mtDNA content differences were associated with nuclear driver gene choice. Our comprehensive characterisation of mitochondrial genomes and expression patterns demonstrates that both germline and somatic genetic variation influence tumour mtDNA content, mutation patterns, and gene expression.Keywords
This publication has 63 references indexed in Scilit:
- The interplay of p38 MAPK signaling and mitochondrial metabolism, a dynamic target in cancer and pathological contextsBiochemical Pharmacology, 2024
- Mitochondrial DNA is a major source of driver mutations in cancerTrends in Cancer, 2022
- Mutational landscape of a chemically-induced mouse model of liver cancerJournal of Hepatology, 2018
- Universal Patterns of Selection in Cancer and Somatic TissuesCell, 2017
- MITOS: Improved de novo metazoan mitochondrial genome annotationMolecular Phylogenetics and Evolution, 2013
- Cellular and molecular mechanisms of mitochondrial functionBest Practice & Research Clinical Endocrinology & Metabolism, 2012
- In vivo mutagenesis reveals that OriL is essential for mitochondrial DNA replicationEMBO Reports, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Heteroplasmic mitochondrial DNA mutations in normal and tumour cellsNature, 2010
- The cancer genomeNature, 2009